Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806

    NEXT STORY
    Translate Bio to Participate in Upcoming Investor Conferences
    PREV STORY
    XORTX Shares Findings of New Diabetes Study Supporting Uric Acid as an Independent Risk Factor
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Benco Family Foundation supports First International Oral Cancer Symposium

    NEW YORK, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Leaders in the dental community unite ...

    author_avatar
    NASDAQ Market News

    Targovax to present at Biologics World Nordic 2018

    Oslo, Norway, 27 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company ...

    author_avatar
    NASDAQ Market News

    OncoMed Pharmaceuticals Completes Enrollment of Phase 2 YOSEMITE Clinical Trial of Demcizumab in Pancreatic Cancer

    REDWOOD CITY, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a ...

    author_avatar
    NASDAQ Market News